Skip to main content

Table 3 Treatment responses at day 28 after PCR correction for the first episode in the per- protocol patient populationa

From: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Treatment response ASAQ AL Total
  Number (%)
Overall population (n = 183) (n = 181) (n = 364)
   Late clinical failure 0 (0) 3 (1.7) 3 (0.6)
   Late parasitological failure 1 (0.5) 2 (1.1) 3 (0.8)
   Adequate clinical and parasitological response 181 (98.9) 175 (98.7) 356 (97.8)
   Not applicable 1 (0.5) 1 (0.6) 2 (0.5)
<12 years old (n = 100) (n = 100) (n = 200)
   Late clinical failure 0 (0.0) 3 (3.0) 3 (1.5)
   Late parasitological failure 1 (1.0) 1 (1.0) 2 (1.0)
   Adequate clinical and parasitological response 98 (98.0) 95 (95.0) 193 (96.5)
   Not applicable 1 (1.0) 1 (1.0) 2 (1.0)
12 years old (n = 83) (n = 82) (n = 164)
   Late parasitological failure 0 (0.0) 1 (1.2) 1 (0.6)
   Adequate clinical and parasitological response 83 (100.0) 80 (97.6) 163 (99.8)
  1. aAll patients who completed the study protocol without any major protocol deviation in treatment evaluation.